• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国东海岸成年人血脂异常与炎症的关系:一项横断面研究。

The relationship between dyslipidemia and inflammation among adults in east coast China: A cross-sectional study.

机构信息

Department of General Medicine, The First Hospital of Quanzhou affiliated to Fujian Medical University, Quanzhou, China.

Department of Mathematics, Virginia Tech, Blacksburg, VA, United States.

出版信息

Front Immunol. 2022 Aug 11;13:937201. doi: 10.3389/fimmu.2022.937201. eCollection 2022.

DOI:10.3389/fimmu.2022.937201
PMID:36032093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9403313/
Abstract

OBJECTIVE

Dyslipidemia is one of the major public health problems in China. It is characterized by multisystem dysregulation and inflammation, and oxidant/antioxidant balance has been suggested as an important factor for its initiation and progression. The objective of this study was to determine the relationship between prevalence of dyslipidemia and measured changes in the levels of proinflammatory cytokines (IL-6, TNF-a, and MCP-1), thiobarbituric acid-reactant substances (TBARS), and serum total antioxidant capacity (TAC) in serum samples.

STUDY DESIGN

A cross-sectional survey with a purposive sampling of 2,631 enrolled participants (age 18-85 years) was performed using the adult population of long-term residents of the municipality of east coast China in Fujian province between the years 2017 and 2019. Information on general health status, dyslipidemia prevalence, and selected mediators of inflammation was collected through a two-stage probability sampling design according to socioeconomic level, sex, and age.

METHODS

The lipid profile was conducted by measuring the levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG) with an autoanalyzer. Dyslipidemia was defined according to National Cholesterol Education Program Adult Treatment Panel III diagnostic criteria, and patients with it were identified by means of a computerized database. Serum parameters including IL-6/TNF-a/MCP-1, TBARS, and TAC were measured in three consecutive years. Familial history, education level, risk factors, etc. were determined. The association between dyslipidemia and serum parameters was explored using multivariable logistic regression models. Sociodemographic, age, and risk factors were also investigated among all participants.

RESULTS

The mean prevalence of various dyslipidemia in the population at baseline (2017) was as follows: dyslipidemias, 28.50%; hypercholesterolemia, 26.33%; high LDL-C, 26.10%; low HDL-C, 24.44%; and hypertriglyceridemia, 27.77%. A significant effect of aging was found among all male and female participants. The mean levels of serum Il-6/TNF-a/MCP-1 were significantly higher in all the types of dyslipidemia among male participants. Female participants with all types of dyslipidemia but low HDL-C showed an elevation of IL-6 and MCP-1 levels, and those with dyslipidemias and hypercholesterolemia presented higher levels of TNF-a compared to the normal participants. The oxidative stress marker TBARS increased among all types of dyslipidemia except hypertriglyceridemia. All participants with different types of dyslipidemia had a lower total antioxidant capacity. Correlation analysis showed that cytokines and TBARS were positively associated with age, obesity, and diabetes mellitus, but not sex, sedentary leisure lifestyle, hypertension, and CVD/CHD history. The activity of TAC was negatively associated with the above parameters.

CONCLUSIONS

The correlation between the prevalence of dyslipidemia and the modification of inflammation status was statistically significant. The levels of proinflammatory cytokines, oxidative stress, and antioxidant capacity in serum may reflect the severity of the lipid abnormalities. These promising results further warrant a thorough medical screening in enhanced anti-inflammatory and reduced oxidative stress to better diagnose and comprehensively treat dyslipidemia at an early stage.

摘要

目的

血脂异常是中国的主要公共卫生问题之一。其特征为多系统失调和炎症,氧化应激/抗氧化平衡被认为是其发生和进展的重要因素。本研究旨在确定血脂异常的患病率与促炎细胞因子(IL-6、TNF-a 和 MCP-1)、硫代巴比妥酸反应物(TBARS)和血清总抗氧化能力(TAC)水平在血清样本中测量的变化之间的关系。

研究设计

2017 年至 2019 年,采用中国福建省东海岸市区成年常住居民的两阶段概率抽样设计,对 2631 名参与者(年龄 18-85 岁)进行了横断面调查。通过两阶段概率抽样设计,根据社会经济水平、性别和年龄,收集了一般健康状况、血脂异常患病率和选定的炎症介质等信息。

方法

采用自动分析仪测量总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)和甘油三酯(TG)的血脂谱。根据国家胆固醇教育计划成人治疗专家组 III 诊断标准定义血脂异常,通过计算机数据库识别血脂异常患者。连续三年测量血清参数,包括 IL-6/TNF-a/MCP-1、TBARS 和 TAC。确定家族史、教育水平、危险因素等。采用多变量逻辑回归模型探讨血脂异常与血清参数之间的关系。还对所有参与者进行了社会人口统计学、年龄和危险因素等方面的调查。

结果

人群基线(2017 年)各种血脂异常的平均患病率如下:血脂异常 28.50%;高胆固醇血症 26.33%;高 LDL-C 血症 26.10%;低 HDL-C 血症 24.44%;高甘油三酯血症 27.77%。在所有男性和女性参与者中,均发现了年龄的显著影响。在所有男性参与者中,所有类型的血脂异常的血清 Il-6/TNF-a/MCP-1 水平均明显升高。所有患有血脂异常和高胆固醇血症的女性参与者的 IL-6 和 MCP-1 水平升高,而与正常参与者相比,患有血脂异常和高胆固醇血症的女性参与者的 TNF-a 水平升高。除高甘油三酯血症外,所有类型的血脂异常均导致氧化应激标志物 TBARS 升高。所有患有不同类型血脂异常的参与者的总抗氧化能力均降低。相关性分析表明,细胞因子和 TBARS 与年龄、肥胖和糖尿病呈正相关,但与性别、久坐的休闲生活方式、高血压和 CVD/CHD 病史无关。TAC 的活性与上述参数呈负相关。

结论

血脂异常的患病率与炎症状态的改变之间存在统计学显著相关性。血清中促炎细胞因子、氧化应激和抗氧化能力的水平可能反映了脂质异常的严重程度。这些有希望的结果进一步证明,需要进行彻底的医学筛查,以增强抗炎和减少氧化应激,从而更好地在早期诊断和全面治疗血脂异常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d97/9403313/53a8c519fdb5/fimmu-13-937201-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d97/9403313/5d34bec83729/fimmu-13-937201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d97/9403313/515103d7a6b8/fimmu-13-937201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d97/9403313/1da320103663/fimmu-13-937201-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d97/9403313/53a8c519fdb5/fimmu-13-937201-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d97/9403313/5d34bec83729/fimmu-13-937201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d97/9403313/515103d7a6b8/fimmu-13-937201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d97/9403313/1da320103663/fimmu-13-937201-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d97/9403313/53a8c519fdb5/fimmu-13-937201-g004.jpg

相似文献

1
The relationship between dyslipidemia and inflammation among adults in east coast China: A cross-sectional study.中国东海岸成年人血脂异常与炎症的关系:一项横断面研究。
Front Immunol. 2022 Aug 11;13:937201. doi: 10.3389/fimmu.2022.937201. eCollection 2022.
2
Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.土耳其成年人血脂异常及相关危险因素的患病率:特拉布宗血脂研究
Endocrine. 2008 Aug-Dec;34(1-3):36-51. doi: 10.1007/s12020-008-9100-z. Epub 2008 Nov 12.
3
Prevalence and factors associated with dyslipidemia in Bangladeshi adults.孟加拉国成年人血脂异常的患病率及相关因素。
PLoS One. 2023 Jan 20;18(1):e0280672. doi: 10.1371/journal.pone.0280672. eCollection 2023.
4
Lipid Profile and the Frequency of Dyslipidemia in Iranian Adolescents with Severe Obesity, Who Were Candidates for Bariatric Surgery.脂质谱与伊朗严重肥胖青少年接受减重手术候选人的血脂异常频率。
Obes Surg. 2024 Feb;34(2):618-624. doi: 10.1007/s11695-023-07038-8. Epub 2024 Jan 8.
5
Prevalence of dyslipidemia and its associated factors among university academic staff and students in Bangladesh.孟加拉国高校教职工和学生血脂异常的患病率及其相关因素分析。
BMC Cardiovasc Disord. 2023 Jul 21;23(1):366. doi: 10.1186/s12872-023-03399-1.
6
[Prevalence of dyslipidemia among residents aged 18-69 years in Shandong province of China, 2011].[2011年中国山东省18 - 69岁居民血脂异常患病率]
Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Mar;50(3):230-4. doi: 10.3760/cma.j.issn.0253-9624.2016.03.008.
7
Threshold-Effect Association of Dietary Cholesterol Intake with Dyslipidemia in Chinese Adults: Results from the China Health and Nutrition Survey in 2015.膳食胆固醇摄入量与中国成年人血脂异常的阈效应关联:来自 2015 年中国健康与营养调查的结果。
Nutrients. 2019 Nov 27;11(12):2885. doi: 10.3390/nu11122885.
8
Alcohol intake and dyslipidemia in male patients with hypertension and diabetes enrolled in a China multicenter registry.饮酒与参加中国多中心登记研究的高血压合并糖尿病男性患者的血脂异常。
J Clin Hypertens (Greenwich). 2023 Feb;25(2):183-190. doi: 10.1111/jch.14638. Epub 2023 Jan 19.
9
[Prevalence trends and related factors of hypertension patients complicating with dyslipidemia in community of Guandong province between 2013 and 2018].2013年至2018年广东省社区高血压合并血脂异常患者的患病率趋势及相关因素
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Oct 24;49(10):986-992. doi: 10.3760/cma.j.cn112148-20210311-00214.
10
[Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].[吉林省社区糖尿病患者血脂异常情况分析]
Wei Sheng Yan Jiu. 2014 Sep;43(5):743-8.

引用本文的文献

1
A High-Fat Diet Increases Kidney Fibrosis Through Regulating TGF-β and PDGF-β Signaling Pathways in Normotensive and Hypertensive Rat Models.高脂饮食通过调节正常血压和高血压大鼠模型中的TGF-β和PDGF-β信号通路增加肾纤维化。
Int J Mol Sci. 2025 Aug 20;26(16):8031. doi: 10.3390/ijms26168031.
2
Trends in high remnant cholesterol level and its risk factors among US adults using NHANES data from 1999 to 2020: a serial cross-sectional study.利用1999年至2020年美国国家健康与营养检查调查(NHANES)数据分析美国成年人高残余胆固醇水平及其风险因素的趋势:一项系列横断面研究
BMJ Open. 2025 Jun 17;15(6):e095079. doi: 10.1136/bmjopen-2024-095079.
3

本文引用的文献

1
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy.载脂蛋白 B 降解酶 9 血浆水平与无动脉粥样硬化性心血管疾病史的家族性高胆固醇血症患者的机械血管损伤相关:为期 6 个月的附加性载脂蛋白 B 降解酶 9 抑制剂治疗的结果。
Biomolecules. 2022 Apr 9;12(4):562. doi: 10.3390/biom12040562.
2
Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US.在美国动脉粥样硬化性心血管疾病患者登记库GOULD中,降脂疗法两年以上的使用情况。
JAMA Cardiol. 2021 Sep 1;6(9):1060-1068. doi: 10.1001/jamacardio.2021.1810.
3
Basic Science Research in Frozen Shoulder: Current Updates.
肩周炎的基础科学研究:当前进展
Indian J Orthop. 2024 Dec 2;59(6):774-784. doi: 10.1007/s43465-024-01294-1. eCollection 2025 Jun.
4
Impact of age on outcomes and hospital costs of urgent laparoscopic cholecystectomy for acute cholecystitis: a retrospective cohort study.年龄对急性胆囊炎急诊腹腔镜胆囊切除术的结局及住院费用的影响:一项回顾性队列研究
BMC Surg. 2025 May 24;25(1):228. doi: 10.1186/s12893-025-02963-0.
5
Adherence to the Mediterranean Diet and Risk of Depression: A Cohort Study in Chinese Community Residents.坚持地中海饮食与抑郁症风险:一项针对中国社区居民的队列研究。
Nutrients. 2025 Mar 7;17(6):942. doi: 10.3390/nu17060942.
6
Therapeutic effects of kecemcem leaves extract ( (L.f.) Kurz) on LDL levels, cytokines, and microscopic liver changes in hyperlipidemic rat model.凯塞姆塞姆叶提取物((L.f.) Kurz)对高脂血症大鼠模型低密度脂蛋白水平、细胞因子及肝脏微观变化的治疗作用。
Open Vet J. 2025 Mar;15(3):1310-1321. doi: 10.5455/OVJ.2025.v15.i3.22. Epub 2025 Mar 31.
7
High-Intensity Interval Training Enhances the Positive Effect of Pentoxifylline on Lipid Profile and Inflammatory Markers in an Endometriosis Animal Model.高强度间歇训练增强己酮可可碱对子宫内膜异位症动物模型血脂谱和炎症标志物的积极作用。
Biomed Res Int. 2025 Mar 10;2025:6742953. doi: 10.1155/bmri/6742953. eCollection 2025.
8
The inverse relationship between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and testosterone in adult males in the United States: a cross-sectional study based on the NHANES database.美国成年男性中非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值和睾酮之间的负相关关系:一项基于美国国家健康与营养检查调查(NHANES)数据库的横断面研究
Front Endocrinol (Lausanne). 2025 Mar 14;16:1478124. doi: 10.3389/fendo.2025.1478124. eCollection 2025.
9
Gender-specific association between a novel atherogenic index of plasma, metabolic parameters and inflammation among obese adults.肥胖成年人血浆新型致动脉粥样硬化指数、代谢参数与炎症之间的性别特异性关联。
BMC Endocr Disord. 2025 Feb 13;25(1):38. doi: 10.1186/s12902-024-01813-z.
10
Cholesterol, triglycerides, HDL, and nitric oxide as determinants of resting heart rate variability in non-hospitalized mild post-COVID individuals: a cross-sectional study.胆固醇、甘油三酯、高密度脂蛋白和一氧化氮作为非住院轻症新冠康复者静息心率变异性的决定因素:一项横断面研究
BMC Cardiovasc Disord. 2025 Jan 31;25(1):69. doi: 10.1186/s12872-025-04523-z.
Lipid Peroxidation and Antioxidant Supplementation in Neurodegenerative Diseases: A Review of Human Studies.
神经退行性疾病中的脂质过氧化与抗氧化剂补充:人体研究综述
Antioxidants (Basel). 2020 Nov 13;9(11):1128. doi: 10.3390/antiox9111128.
4
Exploring health literacy in Wuhan, China: a cross-sectional analysis.探究中国武汉的健康素养:一项横断面分析。
BMC Public Health. 2020 Sep 17;20(1):1417. doi: 10.1186/s12889-020-09520-9.
5
Atherosclerosis Prediction with High Sensitivity C-Reactive Protein (hs-CRP) and Related Risk Factor in Patient with Dyslipidemia.高敏C反应蛋白(hs-CRP)及相关危险因素对血脂异常患者动脉粥样硬化的预测作用
Open Access Maced J Med Sci. 2019 Nov 14;7(22):3887-3890. doi: 10.3889/oamjms.2019.526. eCollection 2019 Nov 30.
6
Approaches for deciphering the molecular basis of disease and its translational benefits.破译疾病分子基础的方法及其转化效益。
Int Rev Immunol. 2019;38(6):247-248. doi: 10.1080/08830185.2019.1689654.
7
PCSK9 and inflammation: a review of experimental and clinical evidence.PCSK9 与炎症:实验与临床证据的综述。
Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):237-245. doi: 10.1093/ehjcvp/pvz022.
8
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia.分析伴或不伴有家族性高胆固醇血症的高脂血症患者的 S100A12 血浆水平。
Acta Diabetol. 2019 Aug;56(8):899-906. doi: 10.1007/s00592-019-01338-1. Epub 2019 Apr 8.
9
Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand.泰国全国性研究:糖尿病患者并发症相关血脂异常的流行情况。
Lipids Health Dis. 2019 Apr 6;18(1):90. doi: 10.1186/s12944-019-1034-3.
10
Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology.确定降脂治疗的抗炎反应:欧洲心脏病学会动脉粥样硬化和血管生物学工作组的立场文件。
Cardiovasc Res. 2019 Jan 1;115(1):10-19. doi: 10.1093/cvr/cvy293.